Filorga Paris
Filorga Paris NCEF-Essence Multi-Correction Lotion - 150 ml
Regular price
€29,95
Regular price
Sale price
€29,95
Unit price
per
Pickup currently unavailable at
Filorga Paris NCEF-Essence Multi-Correction Lotion - 150 ml
Regular price
€29,95
Regular price
Sale price
€29,95
Unit price
per
Pay with
Full Description
Filorga Paris NCEF-Essence Multi-Correction Lotion - 150 ml Kaufen bei Blisso.
| Marke | Filorga Paris |
| EAN | 3401360156456 |
| Zutaten | Aqua (Water, Eau), Glycerine, Butyleenglycol, Capryloyl Glycine, Citroenzuur, Dimethicon Peg-7 Fosfaat, Natriumhydroxide, Natrium Polyacrylaat Zetmeel, Ethylhexyl Salicylaat, Dinatrium Edta, Parfum (Geur), Natriumchloromiet, Sucrose Spin osa Geumpina , Butyl Methyoxydibenzoylmethaan, Salvia Sclarea (Clary) Extract, Glyceryl Linoleaat, Diethylhexyl Syringylideenemalonaat, Prunus Amygdalus Dulcis (Zoete Amandel) Olie, Kaliumsorbaat, Natriumbenzoaat, Glucose, Glucose, Glucose, Extract, Pentaerythrityl-Butyl-Di-Di-Hydroxine Kaliumchloride, Calciumchloride, Fenoxyethanol, Natriumhyaluronaat, Magnesiumsulfaat, Glutamine, Natriumfosfaat, Alcohol, Ascorbinezuur, Natriumacetaat, Tris (Tetraminol Hydroxyl), Alanine, Histidine Hcl, Valine, Leucine, Threonine, Isoleucine, Tryalanine, Fenylptofaan Tyrosine, Glycine, Polysorbaat 80, Serine e, Cystine, Cyanocobalamine, Glutathion, Asparagine, Asparaginezuur, Ornithine Hcl, Glutaminezuur, Nicotinamide Adenine Dinucleotide, Tocoferol, Proline, Methionine, Taurine, Hydroxyproline, Glucosamine Hcl, Co-enzym A, Ci 17 Natriumglucine, Retinyl 33 Difosfaat Acetaat, Inositol, Niacine, Niacinamide, Pyridoxine Hcl, Biotine, Calciumpantothenaat, Riboflavine, Natriumtocoferylfosfaat, Thiamine Hcl, Foliumzuur. |
Specifications
| Content | 150.0 ml |
| Skin type | Alle Hauttypen, Müde Haut |
| Article number | 17132 |
| EAN | 3401360156456 |
Ingredients
Fügen Sie relevante Textinhalte mit dem Richtext-Editor hinzu. Beachten Sie, dass Sie in diesen Inhalt auch Links und grundlegende Formatierungen einfügen können, z. B. Fett und Kursiv .
